Search research articles
Contact Us
Filters
Showing results (291-300 of 294) with videos related to
Page
of 30
Sort By:
You have reached the last page of results.
This site can display upto 294 results.
Journal of Medicinal Chemistry
|
October 29, 2024
Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against <i>Mycobacterium abscessus</i> and <i>Mycobacterium avium</i>, Two Emerging Human Pathogens
Matheus Andrade Meirelles, Vitor M Almeida, Jaryd R Sullivan, et al.
Nature
|
August 21, 2014
Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis
Kirsten I Bos, Kelly M Harkins, Alexander Herbig, et al.
Nature Chemical Biology
|
August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomes
Jeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.
Journal of Personalized Medicine
|
January 6, 2018
Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience
Robyn Fossey, David Kochan, Erin Winkler, et al.
Page
of 30
Search research articles
Search
Showing results (291-300 of 294) with videos related to
Sort By:
Page
of 30
You have reached the last page of results.
This site can display upto 294 results.
Journal of Medicinal Chemistry
|
October 29, 2024
Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against <i>Mycobacterium abscessus</i> and <i>Mycobacterium avium</i>, Two Emerging Human Pathogens
Matheus Andrade Meirelles, Vitor M Almeida, Jaryd R Sullivan, et al.
Nature
|
August 21, 2014
Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis
Kirsten I Bos, Kelly M Harkins, Alexander Herbig, et al.
Nature Chemical Biology
|
August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomes
Jeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.
Journal of Personalized Medicine
|
January 6, 2018
Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience
Robyn Fossey, David Kochan, Erin Winkler, et al.
Page
of 30